Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Rhythm Biosciences Ltd. ( (AU:RHY) ) just unveiled an update.
Rhythm Biosciences Ltd. has announced the application for quotation of 483,871 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective June 2, 2025. This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, impacting its operations and stakeholder interests positively.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development of diagnostic technologies. The company is primarily engaged in creating products that aid in the early detection of diseases, with a market focus on enhancing healthcare outcomes through innovative solutions.
Average Trading Volume: 231,399
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$18.84M
Learn more about RHY stock on TipRanks’ Stock Analysis page.